SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-May-24 9:00 PM View: | MannKind Corp. (MNKD) | 24-May-24 | Payment of Exercise | 16,151 | $4.78 | $77,201.80 | (4%) 367.9K to 351.75K | |
17-May-24 9:00 PM View: | MannKind Corp. (MNKD) | 15-May-24 | Grant | 129,000 | -- | -- | 35% 367.9K to 496.9K | |
05-Feb-24 6:00 AM View: | MannKind Corp. (MNKD) | 04-Feb-24 | Grant | 152,905 | $3.27 | $499,999.00 | 71% 215.0K to 367.9K | |
05-Feb-24 6:00 AM View: | MannKind Corp. (MNKD) | 31-Dec-23 | Grant | 5,000 | $3.09 | $15,450.00 | 2% 210.0K to 215.0K | |
26-May-23 9:00 PM View: | MannKind Corp. (MNKD) | 25-May-23 | Grant | 210,000 | -- | -- | 100% 0 to 210.0K | |
05-Mar-21 6:33 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Mar-21 | Grant | 11,125 | -- | -- | 150% 7.4K to 18.53K | |
21-Sep-20 8:26 AM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Sep-20 | Grant | 3,015 | -- | -- | 7% 41.4K to 44.41K | |
12-Mar-19 4:11 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-19 | Grant | 9,045 | -- | -- | 28% 32.35K to 41.4K | |
27-Dec-18 8:07 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-18 | Grant | 2,100 | -- | -- | 7% 30.25K to 32.35K | |
12-Sep-18 4:07 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Sep-18 | Grant | 2,100 | -- | -- | 7% 28.15K to 30.25K | |
03-Aug-18 7:46 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Aug-18 | Option Exercise | 6,250 | $16.50 | $103,125.00 | 22% 28.15K to 34.4K | |
03-Aug-18 7:46 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Aug-18 | Market Option Sale (Planned) | 6,250 | $24.69 | $154,322.00 | (18%) 34.4K to 28.15K | 97% |
03-Jul-18 5:33 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Jul-18 | Market Sale (Planned) | 5,000 | $29.61 | $148,050.00 | (15%) 33.15K to 28.15K | 98% |
22-May-18 4:33 PM View: | Acorda Therapeutics, Inc. (ACOR) | 18-May-18 | Option Exercise | 25,000 | $16.50 | $412,500.00 | 75% 33.15K to 58.15K | |
22-May-18 4:33 PM View: | Acorda Therapeutics, Inc. (ACOR) | 18-May-18 | Market Option Sale (Planned) | 25,000 | $23.66 | $591,588.00 | (43%) 58.15K to 33.15K | 97% |
05-Dec-17 7:36 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-17 | Market Sale (Planned) | 11,050 | $20.53 | $226,893.00 | (25%) 44.2K to 33.15K | 96% |
03-Mar-17 4:03 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Mar-17 | Grant | 4,200 | -- | -- | 10% 40.0K to 44.2K | |
05-Dec-16 5:06 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-16 | Market Sale (Planned) | 10,000 | $20.74 | $207,442.00 | (20%) 50.0K to 40.0K | 96% |
06-Jul-16 8:17 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Jul-16 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |